Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

被引：3

作者：

Suiter, Tobias M. ^{[1
]}

Mannucci, Pier Mannuccio ^{[2
,3
]}

Kempton, Christine L. ^{[4
,5
]}

Laffan, Michael ^{[6
]}

Romond, Edward H. ^{[7
]}

Shapiro, Amy D. ^{[8
]}

Birschmann, Ingvild ^{[9
]}

Ragni, Margaret V. ^{[10
,11
]}

Gill, Joan Cox ^{[12
]}

Yee, Thynn Thynn ^{[13
,14
]}

Klamroth, Robert ^{[15
]}

Horling, Frank M. ^{[16
]}

Reipert, Birgit M. ^{[1
]}

Turecek, Peter L. ^{[1
]}

Varadi, Katalin ^{[1
]}

Chapman, Miranda ^{[1
]}

Engl, Werner ^{[1
]}

Wong, Wing Yen ^{[17
]}

Ewenstein, Bruce M. ^{[17
]}

机构：

[1] Baxter Innovat GmbH, Vienna, Austria

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Dept Internal Med & Med Specialties, Milan, Italy

[3] Fdn Milano, Sci Direct, Milan, Italy

[4] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA

[5] Emory Univ, Sch Med, Dept Hematol Oncol, Atlanta, GA USA

[6] Imperial Coll Sch Med, Hammersmith Hosp, Dept Hematol, London, England

[7] Univ Kentucky, Hemophilia Treatment Ctr, Lexington, KY USA

[8] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA

[9] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-3000 Hannover, Germany

[10] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA USA

[11] Hemophilia Ctr Western Penn, Pittsburgh, PA USA

[12] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[13] Royal Free Hosp, Haemophilia Ctr, London NW3 2QG, England

[14] Royal Free Hosp, Thrombosis Unit, London NW3 2QG, England

[15] Vivantes Klinikum Friedrichshain, Klini Innere Med Angiol & Haemostaseol, Berlin, Germany

[16] Baxter BioSci, Immunol, Vienna, Austria

[17] Baxter Healthcare Corp, Westlake Village, CA USA

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

10.1182/blood.V118.21.2275.2275

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：987 / 988

页数：2

共 50 条

[21] Von Willebrand factor and von Willebrand disease - Preface
Michiels, JJ
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (02) : VII - VII
[22] Von willebrand factor (VWF) assays and the diagnosis of von willebrand disease (VWD). Who follows the guidelines?
Jennings, I
Kitchen, D.
Woods, T.
Munroe-Peart, S.
Brown, L.
Kitchen, S.
Walker, I
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 152 - 153
[23] Von Willebrand factor (VWF) assays and the diagnosis of von Willebrand disease (VWD). Who follows the guidelines?
Jennings, I.
Kitchen, D. P.
Woods, T. A. L.
Munroe-Peart, S.
Brown, L.
Kitchen, S.
Walker, I. D.
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 54 - 54
[24] Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
Haberichter, Sandra L.
Balistreri, Michael
Christopherson, Pamela
Morateck, Patricia
Gavazova, Stefana
Bellissimo, Daniel B.
Manco-Johnson, Marilyn J.
Gill, Joan Cox
Montgomery, Robert R.
BLOOD, 2006, 108 (10) : 3344 - 3351
[25] Acquired von Willebrand disease:: potential contribution of the VWF:CB to the identification of functionally inhibiting auto-antibodies to von Willebrand factor
Coleman, R.
Favaloro, E. J.
Soltani, S.
Keng, T. B.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) : 2085 - 2088
[26] Platelet von Willebrand factor (VWF) MRNA analysis in patients with von Willebrand disease (VWD) and null mutations in VWF gene
Giacomelli, S.
Rodeghiero, F.
Castaman, G.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 839 - 839
[27] Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease
Favaloro, Emmanuel J.
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (01) : 114 - 118
[28] The increasing maturity of the von Willebrand factor collagen binding in von Willebrand disease diagnosis
Favaloro, E. J.
Mohammed, S.
Oliver, S.
HAEMOPHILIA, 2018, 24 (01) : 20 - 23
[29] A new automated chemiluminescent method for the determination of von Willebrand factor ristocetin cofactor activity (VWF:RCO) and von willebrand factor antigen (VWF:AG)
Friedman, K. D.
Jacobi, P. M.
Shaw, M. E.
Endres, J. L.
Haberichter, S. L.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 98 - 99
[30] A mutation in the D4 domain of von Willebrand factor (VWF) results in a variant of type 1 von Willebrand disease with accelerated in vivo VWF clearance.
Gavazova, S
Gill, JC
Scott, JP
Hillery, CA
Friedman, KD
Wetzel, N
Jozwiak, M
Haberichter, SL
Christopherson, P
Montgomery, RR
BLOOD, 2002, 100 (11) : 128A - 128A

← 1 2 3 4 5 →